| Patient | Dorothea Lange |
|---|---|
| Date of birth | 1964-05-26 |
| Identifiers | MRN HR-ML045-SYN; SSN (made up) 000-45-9127 |
| Document date | 2026-04-20 |
| Author | Gwendolyn Ashford-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review after eight weeks of pacing and physical therapy; zoledronic acid infusion; heartburn back off omeprazole. [S]
Ms. Lange has had seven weeks of physical therapy, two sessions a week of submaximal strengthening and warm-water exercise with rest days. Her right ankle-foot orthosis was fitted four weeks ago and she uses a cane outdoors. She has had no falls. She now plans each field day with rest breaks and a seat stick, has a colleague carry the tripod, and rests the day after; she is less tired and the evening aching is less. Home overnight oximetry six weeks ago was normal. She completed the eight-week omeprazole trial two weeks ago and stopped it; within five days the heartburn and regurgitation came back on three or four nights a week. She has no difficulty swallowing, weight loss, vomiting, or black stools. She has taken vitamin D3 daily, saw her dentist last month with no problems, and has not yet returned the 24-hour urine collection: she was away photographing for two weeks. [S]
| Element | Detail |
|---|---|
| Interval change | Physical therapy seven weeks; orthosis fitted; no falls; overnight oximetry normal |
| Fatigue | Less with pacing; working two field days a week |
| Heartburn | Returned within five days of stopping omeprazole two weeks ago |
| Bone | Vitamin D taken daily; dental check normal; urine collection not done |
| Today | First zoledronic acid infusion |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired after field days but recovers overnight; weight stable |
| Musculoskeletal | Positive | Milder thigh aching; no new weakness |
| Neurological | Negative | No numbness; no new weakness |
| Respiratory | Negative | No breathlessness |
| Gastrointestinal | Positive | Heartburn and regurgitation three or four nights a week; no difficulty swallowing, vomiting, or black stools |
| Psychiatric | Negative | Mood better; PHQ-9 4 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 2025-06-02 | active | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburn | One capsule once daily before breakfast | Oral route | 2026-02-09 to 2026-04-06 | completed | S |
| Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily | Two tablets once daily | Oral route | 2026-02-25 | active | S |
| Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy | One or two tablets up to every 4 hours as needed | Oral route | 2026-04-20 to 2026-05-18 | completed | S |
| Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year | One infusion once a year | Intravenous route | 2026-04-20 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-20 | Body height | 152 | cm | S |
| 2026-04-20 | Body weight | 50.6 | kg | S |
| 2026-04-20 | Body mass index (BMI) [Ratio] | 21.9 | kg/m2 | S |
| 2026-04-20 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-04-20 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-04-20 | Heart rate | 72 | /min | S |
| 2026-04-20 | Respiratory rate | 14 | /min | S |
| 2026-04-20 | Body temperature | 36.6 | Cel | S |
| 2026-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-20 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | 30-100 ng/mL | Normal | S |
| 2026-04-20 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-04-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 2026-04-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 93 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-04-20 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S |
Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; walks in with the orthosis and a cane |
| Neurological | Strength unchanged from the baseline: left quadriceps 4/5, right quadriceps 3+/5, right ankle dorsiflexion 2/5 |
| Gait | With the orthosis, no foot drop and less knee hyperextension; Timed Up and Go 11.8 seconds with the orthosis and cane |
| Skin | No pressure marks from the orthosis |
| Abdomen | Soft; mild epigastric tenderness; healed upper abdominal scar |
| Mouth | Teeth and gums in good repair |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| New fatigue and slowly increasing weakness for about 18 months, in the left leg and both arms as well as the right leg weakened by polio at seven, with aching muscle pain after work and cold intolerance of the right leg; cause to be established | resolved | confirmed | M62.81 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis of post-polio syndrome at the second visit; the paralytic polio of 1902 is documented (D). |
| Post-polio syndrome (modified March of Dimes criteria met): new weakness of the left quadriceps and both shoulder girdles and increased weakness of the right leg, with fatigue, muscle pain, and cold intolerance, more than 50 years after paralytic polio with partial recovery and decades of stable function; nerve conduction normal; EMG chronic reinnervation in both legs and the right deltoid; other causes excluded | active | confirmed | G14 | S — Synthetic modern diagnosis; the childhood polio is documented (D), and her biographer's account of post-polio symptoms later in life is a retrospective interpretation (R). No neurological finding from her lifetime is used. |
| Heartburn and regurgitation after meals and at night for three months, three to four times a week; no difficulty swallowing, weight loss, vomiting, bleeding, or anemia | active | confirmed | R12 | S — Synthetic presenting symptom at the index visit, superseded by the endoscopic diagnosis at the fourth visit. |
| Osteoporosis, worst at the right hip on the polio-weakened side (right femoral neck T-score -2.7; left -1.6; lumbar spine -1.8), with vitamin D insufficiency; no vertebral fracture on assessment; 10-year FRAX risk about 16 percent major osteoporotic and 4.5 percent hip | active | confirmed | M81.8 | S — Synthetic bone density result; disuse of a polio-affected limb lowers bone density on that side. |
| Two falls in the past year without injury, from catching the right foot | active | confirmed | Z91.81 | S — Synthetic fall history at presentation. |
| Surgery for severe stomach ulcers in her early fifties; no ulcer symptoms since; avoids nonsteroidal anti-inflammatory drugs | active | confirmed | Z87.11 | S — Synthetic modern history entry linked to the documented ulcers and surgery of the late 1940s (D); the type of operation is not known. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Strength unchanged; TUG 11.8 seconds with the orthosis and cane |
| Survey | Pain score | Every visit | Completed today | Pain 5 of 10 |
| Survey | Depression screen (PHQ-9) | Periodically | Completed today | PHQ-9 4 |
| Referral | Supervised non-fatiguing exercise (physical therapy) | Twelve weeks | Up to date | Week seven of twelve; tolerating without next-day exhaustion |
| Examination | Orthosis fit and skin check | Every visit | Completed today | Good fit; no pressure marks |
| Examination | Sleep-disordered breathing screen | At diagnosis and with symptoms | Up to date | Overnight oximetry six weeks ago normal: mean saturation 94 percent, desaturation index 3 per hour |
| Imaging | Spirometry | Yearly or with symptoms | Up to date | Normal eight weeks ago; no breathlessness |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing |
| Self-management | Energy conservation and pacing | Every visit | Completed today | Two field days a week with rest breaks and a rest day after each |
| Examination | Fall review | Every visit | Completed today | No falls in eight weeks |
| Medication safety | Zoledronic acid: calcium, vitamin D, kidney function, and dental status | Before each infusion | Completed today | Vitamin D 34, calcium 9.4, creatinine 0.7, eGFR 93; dental check last month normal; infusion given |
| Laboratory | 24-hour urine calcium | At diagnosis | Deferred | Missed, a deviation from the secondary-causes protocol: the collection was not done before the infusion because she was away for two weeks. Normal serum calcium, PTH, phosphate, and alkaline phosphatase make hypercalciuria or hyperparathyroidism unlikely, so the infusion went ahead and no harm is expected. Corrective action: kit reissued with a reminder call, to be collected before the yearly review |
| Medication safety | Proton pump inhibitor trial outcome | At 8 weeks | Completed today | Responded; symptoms returned within five days of stopping |
| Imaging | Upper endoscopy off proton pump inhibitor | When symptoms return after stopping, before long-term therapy | Ordered | Booked in about ten days |
| Medication safety | Sedation precautions before the endoscopy | Before any procedure | Completed today | Reduced doses, oxygen and carbon dioxide monitoring, and warming requested |
Goal progress:
Guideline basis: EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006); Review of the anaesthetic management of patients with post-polio syndrome. Br J Anaesth 2025;134(5):1385-1391 (2025); ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56 (2022); RECLAST (zoledronic acid) injection: prescribing information (acute phase reaction, calcium and kidney checks, osteonecrosis of the jaw) (2026); CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026)
Follow-up: Endoscopy in about ten days. Call if fever or aching after the infusion. Primary care review with the endoscopy result. Next scheduled visit 2026-05-18: endoscopy results and reflux treatment; post-polio syndrome follow-up. [S]